Skip to main content

Acquired Chronic Tubulointerstitial Nephritis

  • Chapter
  • First Online:
Primer on Nephrology

Abstract

Chronic acquired tubulointerstitial disease encompasses a heterogeneous collection of causes of kidney injury. Although there are a number of uncommon and/or regionally specific diagnoses which present in this category, there is also an inadequately defined and, as yet, poorly understood syndrome responsible for a substantial burden of kidney disease morbidity and mortality in low- and middle-income countries. Given the attributes of the renal tubule, chronic injury is most typically due to long-term exogenous toxin exposure, although metabolic, infectious and autoimmune causes are also well described. Chronic acquired tubulointerstitial disease typically presents without clear symptoms, and proteinuria, haematuria and hypertension are often absent, making identification challenging except through estimates of kidney function using serum biomarkers. Renal biopsy will demonstrate tubulointerstitial fibrosis, but the underlying cause is usually ascertained from the clinical history. Although specific therapy may be indicated in certain cases, reduction in exposure to environmental factors is likely to be the key intervention to reduce the impact of these diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bamias G, Boletis J. Balkan nephropathy: evolution of our knowledge. Am J Kidney Dis. 2008;52(3):606–16.

    Article  Google Scholar 

  2. Dubach UC, Rosner B, Pfister E. Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968–1979). N Engl J Med. 1983;308(7):357–62.

    Article  CAS  Google Scholar 

  3. Peraza S, et al. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis. 2012;59(4):531–40.

    Article  Google Scholar 

  4. Iwagami M, et al. Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom. Clin Epidemiol. 2018;10:421–9.

    Article  Google Scholar 

  5. Close H, et al. Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLoS One. 2014;9(3):e90169.

    Article  Google Scholar 

  6. Kessing LV, et al. Use of lithium and anticonvulsants and the rate of chronic kidney disease: a nationwide population-based study. JAMA Psychiat. 2015;72(12):1182–91.

    Article  Google Scholar 

  7. Bendz H, et al. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int. 2010;77(3):219–24.

    Article  CAS  Google Scholar 

  8. Curhan GC, et al. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med. 2004;164(14):1519–24.

    Article  Google Scholar 

  9. Fored CM, et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med. 2001;345(25):1801–8.

    Article  CAS  Google Scholar 

  10. Becker CG, et al. Nephrotic syndrome after contact with mercury. A report of five cases, three after the use of ammoniated mercury ointment. Arch Intern Med. 1962;110:178–86.

    Article  CAS  Google Scholar 

  11. Gerhardt RE, et al. Chronic renal insufficiency from cortical necrosis induced by arsenic poisoning. Arch Intern Med. 1978;138(8):1267–9.

    Article  CAS  Google Scholar 

  12. Katsuma A, et al. Acute renal failure following exposure to metallic mercury. Clin Nephrol. 2014;82(1):73–6.

    CAS  PubMed  Google Scholar 

  13. Sathe K, Ali U, Ohri A. Acute renal failure secondary to ingestion of ayurvedic medicine containing mercury. Indian J Nephrol. 2013;23(4):301–3.

    Article  CAS  Google Scholar 

  14. Inglis JA, Henderson DA, Emmerson BT. The pathology and pathogenesis of chronic lead nephropathy occurring in Queensland. J Pathol. 1978;124(2):65–76.

    Article  CAS  Google Scholar 

  15. Emmerson BT. “Ouch-ouch” disease: the osteomalacia of cadmium nephropathy. Ann Intern Med. 1970;73(5):854–5.

    Article  CAS  Google Scholar 

  16. Nogawa K, Kido T. Biological monitoring of cadmium exposure in itai-itai disease epidemiology. Int Arch Occup Environ Health. 1993;65(1 Suppl):S43–6.

    Article  CAS  Google Scholar 

  17. Hsu LI, et al. Arsenic exposure from drinking water and the incidence of CKD in low to moderate exposed areas of Taiwan: a 14-year prospective study. Am J Kidney Dis. 2017;70(6):787–97.

    Article  CAS  Google Scholar 

  18. Hellstrom L, et al. Cadmium exposure and end-stage renal disease. Am J Kidney Dis. 2001;38(5):1001–8.

    Article  CAS  Google Scholar 

  19. Sommar JN, et al. End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ Health. 2013;12:9.

    Article  CAS  Google Scholar 

  20. Mengs U. Acute toxicity of aristolochic acid in rodents. Arch Toxicol. 1987;59(5):328–31.

    Article  CAS  Google Scholar 

  21. Yang CS, et al. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis. 2000;35(2):313–8.

    Article  CAS  Google Scholar 

  22. Nortier JL, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342(23):1686–92.

    Article  CAS  Google Scholar 

  23. Gokmen MR, et al. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review. Ann Intern Med. 2013;158(6):469–77.

    Article  Google Scholar 

  24. Malir F, et al. Ochratoxin A: 50 years of research. Toxins (Basel). 2016;8(7):191.

    Article  Google Scholar 

  25. Zaied C, et al. Presence of ochratoxin A in Tunisian blood nephropathy patients. Exposure level to OTA. Exp Toxicol Pathol. 2011;63(7–8):613–8.

    Article  CAS  Google Scholar 

  26. Abbara A, Davidson RN, Medscape. Etiology and management of genitourinary tuberculosis. Nat Rev Urol. 2011;8(12):678–88.

    Article  CAS  Google Scholar 

  27. Cohen EP, Robbins ME. Radiation nephropathy. Semin Nephrol. 2003;23(5):486–99.

    Article  Google Scholar 

  28. Bouquegneau A, et al. Anorexia nervosa and the kidney. Am J Kidney Dis. 2012;60(2):299–307.

    Article  Google Scholar 

  29. Zipfel S, et al. Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up study. Lancet. 2000;355(9205):721–2.

    Article  CAS  Google Scholar 

  30. Delanaye P, et al. Cystatin C or creatinine for detection of stage 3 chronic kidney disease in anorexia nervosa. Nephron Clin Pract. 2008;110(3):c158–63.

    Article  CAS  Google Scholar 

  31. Li L, et al. Ileostomy creation in colorectal cancer surgery: risk of acute kidney injury and chronic kidney disease. J Surg Res. 2017;210:204–12.

    Article  Google Scholar 

  32. Correa-Rotter R, Wesseling C, Johnson RJ. CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am J Kidney Dis. 2014;63(3):506–20.

    Article  Google Scholar 

  33. Jayasumana C, et al. Chronic interstitial nephritis in agricultural communities: a worldwide epidemic with social, occupational and environmental determinants. Nephrol Dial Transplant. 2017;32(2):234–41.

    CAS  PubMed  Google Scholar 

  34. Ball S, et al. Why is there so much end-stage renal failure of undetermined cause in UK Indo-Asians? QJM. 2001;94(4):187–93.

    Article  CAS  Google Scholar 

  35. Cohen J. Mesoamerica’s mystery killer. Science. 2014;344(6180):143–7.

    Article  CAS  Google Scholar 

  36. Gonzalez-Quiroz M, et al. Decline in kidney function among apparently healthy young adults at risk of Mesoamerican nephropathy. J Am Soc Nephrol. 2018.

    Google Scholar 

  37. Wijkstrom J, et al. Morphological and clinical findings in Sri Lankan patients with chronic kidney disease of unknown cause (CKDu): similarities and differences with Mesoamerican Nephropathy. PLoS One. 2018;13(3):e0193056.

    Article  Google Scholar 

  38. Wijkstrom J, et al. Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America. Am J Kidney Dis. 2013;62(5):908–18.

    Article  Google Scholar 

Further Reading/Guidelines

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ben Caplin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hendra, H., Harber, M., Caplin, B. (2022). Acquired Chronic Tubulointerstitial Nephritis. In: Harber, M. (eds) Primer on Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-76419-7_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-76419-7_33

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-76418-0

  • Online ISBN: 978-3-030-76419-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics